Baxter International Inc.

BAX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $602.0M $4.97B $968.0M $2.50B $2.01B $2.33B $2.22B $1.42B
Depreciation & Amortization $750.0M $800.0M $759.0M $792.0M $635.0M $712.0M $670.0M $685.0M
Depreciation $596.0M $632.0M $597.0M $613.0M $502.0M $590.0M $572.0M $592.0M
Amortization $154.0M $163.0M $158.0M $169.0M $113.0M $101.0M $81.0M $79.0M
Stock-Based Compensation $107.0M $115.0M $126.0M $126.0M $122.0M $130.0M $119.0M $120.0M
Net Cash from Operating Activities $1.71B $1.65B $1.77B $3.22B $3.20B $3.11B $2.82B $3.00B
Investing Activities
Capital Expenditures $616.0M $719.0M $911.0M $925.0M $706.0M $1.16B $960.0M $963.0M
Business Acquisitions $686.0M $48.0M $34.0M $95.0M $3.67B $515.0M $590.0M $319.0M
Net Cash from Investing Activities $-1.29B $-715.0M $-1.81B $-1.54B $-5.36B $-1.57B $-1.43B $-1.26B
Financing Activities
Dividends Paid $315.0M $268.0M $910.0M $1.10B $1.02B $804.0M $709.0M $688.0M
Stock Repurchases $564.0M $292.0M — $550.0M $913.0M $1.48B $1.58B $1.45B
Net Cash from Financing Activities $93.0M $-324.0M $-481.0M $-1.40B $1.65B $-1.12B $-1.14B $-1.72B
Net Change in Cash $593.0M $588.0M $-712.0M $192.0M $-537.0M $365.0M $220.0M $-101.0M
Free Cash Flow $1.10B $935.0M $860.0M $2.29B $2.49B $1.95B $1.86B $2.04B
← Newer Page 2 of 3 Older →